Home Premium Content Shelton’s NanoViricides announces progress on clinical drug treatment for Covid-19

Shelton’s NanoViricides announces progress on clinical drug treatment for Covid-19

SHARE

The company is working to complete the necessary required safety pharmacology studies that would allow it to apply to the FDA for permission to begin human clinical trials.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email